P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P22303 |
ACES_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P22303 |
ACES_HUMAN |
Glaucoma [ICD-11: 9C61] |
P22303 |
ACES_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P22303 |
ACES_HUMAN |
Oesophageal/gastroduodenal disorder [ICD-11: DD90] |
P22303 |
ACES_HUMAN |
Pediculosis [ICD-11: 1G00] |
P22303 |
ACES_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P22303 |
ACES_HUMAN |
Parasitic worm infestation [ICD-11: 1F90] |
P22303 |
ACES_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P22303 |
ACES_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P22303 |
ACES_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P22303 |
ACES_HUMAN |
Substance abuse [ICD-11: 6C40] |
P22303 |
ACES_HUMAN |
Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] |
P22303 |
ACES_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22303 |
ACES_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
P22303 |
ACES_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |